There have been very few cases of people who have overdosed on Neupogen. Overdose effects may potentially include strokes, heart attacks, or kidney failure. If white blood cells increase too much during a Neupogen overdose, a procedure called leukapheresis may be performed. Treatment may also include supportive care, which consists of treating the symptoms that occur as a result of the overdose.
Neupogen® (filgrastim) is a prescription medication used to stimulate the production of certain white blood cells known as neutrophils. It belongs to a group of medications known as granulocyte colony-stimulating factors (G-CSF). The effects of a Neupogen overdose will vary depending on a number of factors, including the Neupogen dosage and whether it was taken with any other medicines, alcohol, or street drugs. If you happen to overdose on Neupogen, seek immediate medical attention.
Because very few cases of Neupogen overdose have been reported, little is known about what to expect with an overdose. Because Neupogen increases the level of white blood cells, a Neupogen overdose may cause the white blood cells to increase too much. This is known as leukocytosis and can lead to dangerous consequences, such as strokes, heart attacks, and kidney failure.
It is not known what the best treatment for a Neupogen overdose may be. If the white blood cells increase too much, a procedure to remove excess white blood cells from the blood may be necessary. The procedure is called leukapheresis. Treatment may also include supportive care, which consists of treating the symptoms that occur as a result of the overdose.